Table of Contents
This BCC Research report examines the global market for medical biomaterials by geographic region and by market segment, and also provides an in-depth discussion and analysis of the application of biomaterials and a review of new and developing technology platforms.
Use this report to:
- Identify the latest developments into new and innovative implantable biomaterials, their properties, their method of manufacture and intended clinical applications.
- Learn about the main products in each sector and plan a product entry strategy in line with the strengths and weaknesses of the competition.
- Analyze the challenges and potential threats facing the biomaterials industry.
- The global market for implantable biomaterials was worth nearly $75.1 billion in 2013. This market is expected to grow at a compound annual growth rate (CAGR) of 6.7% between 2014 and 2019 resulting in $79.1 billion in 2014 and $109.5 billion global market in 2019.
- The North America market totaled $38.3 billion in 2013. This market should increase to about $40.2 billion in 2014 and should reach about $51.8 billion by 2019, demonstrating a CAGR of 5.2% from 2014 to 2019.
- The Latin American market totaled $3.4 billion in 2013. This market should reach almost $3.8 billion in 2014 and $6.8 billion by 2019, a CAGR of 12.6% from 2014 to 2019.
Introduction & Scope
Biomaterials have made a significant contribution in improving the outcomes of patients suffering from the issues associated with long-term chronic conditions as well
as helping to resolve the problems of traumatic injury. It is anticipated that the use of medical biomaterials will continue to expand rapidly through the emergence of new
and innovative technologies as well as the identification of new applications for products based on biomaterial technologies.
By definition, the use of biomaterials covers a broad area of therapeutic use. In fact, any natural or synthetic material that interfaces with living tissue and/or biological
fluids may be classified as a biomaterial. Even common materials such as polyester have shown usefulness in some biomedical applications. However, certain physical,
chemical and mechanical characteristics render some materials more desirable than others for biological application.
To complicate things further, the determination of these desirable traits depends on the material’s intended use in the body. For example, the material for a bone implant
must exhibit great compressive strength, while the material for a ligament replacement must display far more flexibility and tensile strength. In all cases, however,
a biomaterial must perform compatibly with the body. In other words, the biocompatibility and, in some cases, bioactivity, of the material comprise key factors in
determining whether a new graft or implant succeeds in the body. In order to define biocompatibility, it may be easier to define what it is not, rather than what it is. A biocompatible material disrupts normal body functions as little as possible. Therefore, the material causes no thrombogenic, toxic or allergic inflammatory response when the material is placed in vivo. The material must not stimulate changes in plasma proteins and enzymes or cause an immunologic reaction, nor can it instigate carcinogenic, mutagenic or teratogenic (gross tissue change) effects.
Bioactive materials play a more aggressive role in the body. While a biocompatible material should affect the equilibrium of the body as little as possible, a bioactive
material recruits specific interactions between the material and surrounding tissue. For example, a bioactive material can encourage tissue integration to aid in the fixation of
an implant in the body. Many total hip implants operations today rely partially on a porous coating of hydroxyapatite (HA), a normal component of bone, to help permanently stabilize the stem of the implant in the bone. The coating encourages ingrowth from the surrounding tissue that interlocks within the pores, much like the pieces of a jigsaw puzzle lock together. Although many current medical procedures call for inert biocompatible materials, the increasing understanding of tissue interaction promises many more applications for aggressive bioactive materials.
STUDY GOALS AND OBJECTIVES
The aim of this report is to conduct an initial review of the biomaterials currently in use as implantable medical devices and then to further the discussion with a review of
some of the latest developments into new and innovative biomaterials, their properties, their method of manufacture and intended clinical applications.
The key objective was also to conduct and provide an analysis of the market value, growth rates, market shares and market development, as well as examine the market
dynamics and market factors influencing the growth and development of this market. This report also looks at the challenges and potential threats facing the industry, and
the factors influencing the market shares of the major market suppliers as well as smaller indigenous manufacturers in local markets. The emphasis of this report is to provide the reader with:
- A detailed analysis of the revenues and forecasts for the global implantable biomaterials market, with a more detailed analysis and forecast of the revenues for the global market subdivided by major market subsegments by geographic region and finally by selected country.
- A detailed analysis of the global market share, together with a more detailed analysis of the market share by geographic regions and finally by selected country.
In addition, this analysis provides a:
- Detailed review of the current products and product specifications that are available for all the market segments identified.
- Profile of the individual market subsegments within the major market segments analyzed.
- Review of the major market opportunities through the recognition of specific high-growth and emerging market opportunities.
- Brief description of the historical development for each of the major market segments.
- Profile of the leading suppliers of implantable biomaterials together with related information about specific products.
The study will allow the reader to:
- Evaluate the effect of strategic factors such as technology-driven change and industry consolidation.
- Investigate the current market dynamics driving change in the implantable biomaterials market.
- Assess future growth opportunities in the implantable biomaterials market.
- Review the main products in each sector and plan a product entry strategy in line with the strengths and weaknesses of the competition.
- Utilize the report to help realize an individual company’s position in the marketplace and to provide insight into the future of the market and the opportunities that exist.
SCOPE OF THE REPORT
This market research report focuses on the global market for medical biomaterials by geographic region and by market segment, and also provides an in-depth discussion
and analysis of the application of biomaterials and a review of new and developing technology platforms. This report also examines companies that are actively developing and marketing medical biomaterials around the world. Detailed tables and charts with sales forecasts and market share data are also included.
Products that are used as biomaterials can be segmented by the materials from which they are made; for example:
In addition to the segmentation by material type, medical biomaterials can also be examined by application/therapeutic area as follows:
- Immunology and infection.
- Pulmonary/respiratory disease.
- Plastic surgery.
- Endocrinology and metabolic diseases.
- Dermatology and wound care.
- Oto-Rhino-Laryngology (ORL).
The global market for medical biomaterials has been estimated at $48 billion in 2013, and is expected to more than double by 2019, reaching $102.5 billion. The growth
represents a compound annual growth rate (CAGR) of by the end of the forecast period. In 2013, the cardiovascular biomaterial segment represented the largest single market
segment, accounting for 34.5% of the global biomaterial market, followed by the orthopedic segment. Plastic surgery and wound healing applications are expected to
experience the highest growth in the coming years.
North America is the largest market for biomaterials and is expected to grow at CAGR of 5.2% from 2014 to 2019 due to an increase in the aging population. Due to rising
awareness of biomaterial products in Asia, and increased partnerships and collaborations, the Asian market is expected to grow at a CAGR of 21.5% from 2014 to 2019.
Get Industry Insights. Simply.
Talk to Ahmad
+1 718 618 4302
The biomaterials market is projected to reach 149.17 billion by 2021 million from 70.90 billion in 2016, at a CAGR of 16.0%. Factors such as increasing funds and grants by governments worldwide, rising ...
Description General Report Contents - Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends - Market Drivers & Limiters for each chapter segment - Competitive Analysis for each chapte ...
The Global market for Biomaterials has been estimated to be USD 54.65 billion in 2014 and it is projected to reach USD 115 billion by the end of 2020 at a CAGR of 13.2% during the forecast period from ...